diluted with water and the aqueous layer was extracted with CH2Cl2 (3  100 mL). The combined organic extracts were washed with brine, dried over Na2SO4, and evaporated in vacuo. The residue was dissolved in methanol (200 mL) and K2CO3 (17.3 g, 125 mmol, 2.4 eq.) was added in 4 portions over 20 mins to the solution at rt. After being stirred for 13 h, the solvent was evaporated in vacuo before water (100 mL) was added to the residue and the product was extracted with Et2O (3  100 mL). The combined organic extracts were washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Recrystallization gave the title compound S2 (7.8 g, 83%) as a colorless solid.
m.p. 120124 °C (n-pentane/Et2O) [lit. 1 121122 °C (n-pentane/Et2O)]; IR νmax (thin film): 3418 (O-H), 2980, 2836, 1605, 1509, 1462, 1374, 1285, 1222, 1163, 1122, 1029, 995, 921, 834 3, 148.1, 144.2, 113.5, 106.6, 104.1, 71.4, 56.8, 22 .0. Physical and spectroscopic data are consistent with those previous reported in the literature. 1
4-(Benzyloxy)-2-isopropoxy-1-methoxybenzene (S3)
Phenol S2 (2.0 g, 11 mmol, 1.0 eq.) was dissolved in DMF (22 mL) and cooled to 0 °C before K2CO3 (2.3 g, 16.5 mmol, 1.5 eq.) and benzyl bromide (2.2 mL, 18.7 mmol, 1.7 eq.) were subsequently added to the stirred solution. The stirred solution was left to warm to rt over 13 h, after which time it was quenched with saturated aq. NH4Cl (20 mL) and the product was extracted with Et2O (3  50 mL). The combined organic extracts were washed with brine, dried over Na2SO4 and filtered. The solvent was evaporated in vacuo and the residue was recrystallized to give the title compound S3 (2.94 g, 99%) as colorless needles. m.p. 56-57 °C (n-pentane/Et2O); IR νmax (thin film): 2981, 2889, 1608, 1508, 1457, 1382, 1258, 1227, 1164, 1137, 1080, 1044, 1028, 955 cm -1 ; 1 H NMR (400 MHz, CDCl3) δ m, HC(12, 13, 14) Ar), 6.79 (1H, d , J = 9.1 Hz, HC(3)Ar), 6.60 (1H, s, HC(6) Ar), 6.49 (1H, d , J = 9.1 Hz, HC(4)Ar), 5.00 (2H, s, OC(10)H2Ph), 4.49 (1H, hept, J = 6.1 Hz, OC(9)H), 3 .81 (3H, s, OC(7)H3), 1.35 (6H, d, J = 6.1 Hz, C(8)H3); 13 C NMR (101 MHz, CDCl3) δ = 153. 4, 148.2, 145.0, 137.2, 128.6, 128.0, 127.6, 112.8, 105.0, 104.7, 71.3, 70.7, 56.7, 22 .1; HRMS (CI + ) Found
[M+H] + = 273.1480; C17H21O3 requires 273.1485, ∆1.91 ppm.
1-Bromo-2-fluoro-4-isopropoxy-5-methoxybenzene (S4)
To a solution of 4-bromo-5-fluoro-2-methoxyphenol (11) (1.0 g, 4.5 mmol, 1.0 eq.) in DMSO (10 mL) was added K2CO3 (1.9 g, 14 mmol, 3.0 eq.) and 2-bromopropane (1.3 mL, 14 mmol, 3.0 eq.) before a reflux condenser was attached and the stirred mixture was heated at 70 °C for 5 h. After this time, water (100 mL) and DCM (50 mL) were added after cooling to rt, before the organic layer was separated and dried with MgSO4.
The residue was dry loaded onto SiO2 and purified by flash column chromatography (SiO2; npentane/acetone, 95:5 to 90:10) to give the title compound S4 (1.15 g, 97%) as pale-yellow needles. 
1-(Benzyloxy)-2-bromo-5-isopropoxy-4-methoxybenzene (10)
Method A: A solution of S3 (500 mg, 1.84 mmol, 1.0 eq.) in DMF (2 mL) was cooled to 0 °C before a solution of NBS (340 mg, 1.92 mmol, 1.1 eq.) in DMF (2.5 mL) was added over 30 min via a syringe. After being stirred for 1 h, the reaction mixture was diluted with water at 0 °C and then allowed to warm to rt. The product was extracted with Et2O (3  30 mL) and the combined organic extracts were washed with brine, dried over Na2SO4 and filtered. The solvent was evaporated in vacuo, and recrystallization from c-hexane gave the title compound 10 (620 mg, 97%) as pale orange needles. m.p. 72-73 °C (c-hexane); IR νmax (thin film): 3034, 2976, 2932, 1581, 1501, 1456, 1441, 1394, 1379, 1311, 1268, 1213, 1177, 1110, 1030, 925, 842 cm -1 ; H NMR (400 MHz, CDCl3) δ = m, HC(12, 13, 14) 147.0, 145.9, 136.8, 128.6, 128.0, 127.4, 117.0, 106.0, 103.2, 72.3, 72.1, 56.7, 22.0 
1-(4-Isopropoxy-3-methoxyphenyl)ethan-1-one (S5)
Acetovanillone (500 mg, 3.0 mmol, 1.0 eq.) was dissolved in DMSO (8.7 mL).
Anhydrous K2CO3 (830 mg, 6.0 mmol, 2.0 eq.) was added to the stirred solution, and subsequently 2-bromopropane (420 L, 4.5 mmol, 1.5 eq.) was added in one portion at rt, before the reaction mixture was heated at 55 °C for 3.5 h. The reaction mixture was cooled to rt and diluted with water. The biphasic mixture was extracted with Et2O (3  50 mL) and the combined organic extracts were washed successively with 10% aq. NaOH (30 mL), water (30 mL), and brine (30 mL), before being dried over Na2SO4. The solvent was evaporated in vacuo and recrystallization of the residue gave the title compound S5 (600 mg, 96%) as a pale yellow waxy solid. m.p. 31-32 °C (n-pentane/Et2O); IR νmax (thin film): 2978, 2935, 1672 (C=O), 1585, 1507, 1464, 1416, 1385, 1374, 1356, 1264, 1218, 1175, 1149, 1133, 1108, 1078, 1032, 951, 876, 847, 810cm 197.0, 152.0, 150.0, 130.3, 123.3, 112.8, 110.8, 71.3 , 56.2 , 26.4, 22.0 
2-Bromo-1-(4-isopropoxy-3-methoxyphenyl)ethan-1-one (8)
Acetophenone S5 (139 mg, 0.67 mmol, 1.0 eq.) and (±)-10-camphorsulfonic acid (300 mg, 1.29 mmol, 1.9 eq.) were added to a flame-dried RBF containing acetonitrile (5 mL) over flame-dried 3Å molecular sieves (ca. 500 mg). To the strongly stirred mixture was added NBS (119 mg, 0.67 mmol, 1.0 eq.) before refluxing at 85 °C for 1.5 h. After this time the mixture was cooled to rt before SiO2 (ca. 3.0 g) was added and the solvent was removed in vacuo. The solid mixture was loaded onto a column for purification (SiO2, 80:20) 190.1, 152.8, 150.1, 126.7, 123.9 , 112.6, 111.5, 71.4, 56.2, 30.6, 22.0 195.9, 150.9, 146.9, 144.6, 137.5, 128.4, 127.6, 127.3, 115.9, 115.0, 103.9, 103.8, 73.1, 71.9, 71.4, 56.7, 37.9, 30.9, 22.2, 14.3 
2-[2-(Benzyloxy)-4-isopropoxy-5-methoxyphenyl]-4-(4-isopropoxy-3-methoxyphenyl)-1-(4-methyl-2,6,7-trioxabicyclo[2.2.2]octan-1-yl)butane-1,4-dione (7)
Method A: In a flame-dried RBF flushed with argon, 9 (44.3 mg, 0.10 mmol, 1.0 eq.) was dissolved in THF (1.0 mL) before NaOtBu (2M in THF, 60 L, 0.12 mmol, 1.2 eq.) was added and the resulted solution was left stirring for 20 mins. A solution of 8 (34.5 mg, 0.12 mmol, 1.2 eq.) in THF (1.0 mL) was added dropwise to the stirred solution of 9 via a syringe (addition rate: 6 mL/h). After complete addition, the solution was left to stir for an additional 1.5 h, after which time it was quenched with saturated aq. NH4Cl (5 mL) and extracted with DCM (3  30 mL). The combined organic extracts were dried with Na2SO4, filtered, and the solvent was evaporated in vacuo. The residue was dryloaded onto SiO2 and purified by column chromatography (n-pentane/acetone, 80:20) to give the title compound 7 (64.9 mg, 100%) as colorless needles.
Method B (one-pot):
To a flame-dried Biotage® microwave vial flushed with argon was added 10 (112.4 mg, 0.32 mmol, 1.1 eq.), methyl-OBO-ketone 1 (75 mg, 0.44 mmol, 1.5 eq.), Pd(dtbpf)Cl2 (9.5 mg, 14.5 mol, 5 mol%) and THF (2.5 mL). Subsequently, NaOtBu (2 M in THF, 360 L, 0.73 mmol, 2.5 eq.) was added via a syringe and the vial was flushed with argon for 5 mins after which time the vial was sealed with an aluminium microwave vial cap (Reseal TM septum). The solution was heated at 50
°C for 52 h, after which time a solution of 8 (184 mg, 0.64 mmol, 2.0 eq.) in anhydrous THF (5 mL)
was added dropwise via a syringe (addition rate: 5 mL/h). After complete addition, the solution was left to stir for an additional 30 min at 50 °C, after which time it was left to cool to rt, quenched with saturated aq. NH4Cl (10 mL) and extracted with DCM (3  30 mL). The combined organic extracts were dried with MgSO4, filtered, and the solvent was evaporated in vacuo. The residue was dryloaded onto SiO2 and purified by column chromatography (n-pentane/acetone, 75:25) to give the title compound 7 (161 mg, 78%) as colorless needles. m.p. 151-154 °C (n-pentane/Et2O); IR νmax (thin film): 2976, 2935, 2880, 1741, 1674, 1593, 1508, 1464, 1417, 1263, 1213, 1106, 1069, 1035, 1002, 950 198.2, 196.1, 151.7, 150.0, 149.7, 146.6, 144.9, 137.5, 129.5, 128.5, 127.7, 127.2, 122.7, 118.9, 113.1, 112.7, 111.0, 104.4, 104.1, 73.0, 71.8, 71.7, 71.1, 56.5, 56.0, 41.9, 40.8, 30.8, 22.2, 22 , 2975, 2934, 2872, 2840, 1697, 1623, 1607, 1595, 1519, 1494, 1472, 1447, 1415, 1384, 1276, 1258, 1231, 1220, 1206, 1169, 1148, 1110, 1067, 1027, 1001, 941, 868, 842 2, 150.8, 148.2, 148.0, 147.6, 146.2, 143.5, 132.1, 123.9, 118.8, 116.4, 115.4, 110.4, 109.6, 105.1, 103.9, 98.9, 71.8, 71.5, 56.6, 56.5, 
3-(2,2-Diethoxyethyl)-7-isopropoxy-2-(4-isopropoxy-3-methoxyphenyl)-8-methoxychromeno[3,4-b]pyrrol-4(3H)-one (13b)
In a flame-dried Biotage® microwave vial flushed with argon, 13a (100 mg, 0.23 mmol, 1.0 eq.) was dissolved in DMF (5 mL (27)).
2-[({2-[2-(Benzyloxy)-4-isopropoxy-5-methoxyphenyl]-8-isopropoxy-9-methoxypyrrolo[2,1-a]-isoquinoline-3-carbonyl}oxy)methyl]-2-methylpropane-1,3-diyl diacetate (14)
To an RBF containing 7 (100 mg, 0.16 mmol, 1.0 eq.) and aminoacetaldehyde diethyl acetal (6) (200 mg, 1.50 mmol, 9 eq.) was added a solution of AcOH (10 mL, with added 1 mol% water and ca.
0.001 mol% formic acid) via syringe, before a reflux condenser was attached and the stirred solution was heated at 100 °C over 16 h.
After this time the solution was allowed to cool to rt and poured onto crushed ice, before adjustment to pH 7-8 by the portion wise addition of K2CO3 (as judged by litmus paper). The aqueous layer was extracted with EtOAc (20 mL), the organic layer was collected, dried over MgSO4 and filtered. 5, 147.2, 145.0, 137.7, 134.5, 132.9, 128.4, 127.6, 127.2, 123.9, 123.1, 120.1, 119.2, 115.6, 113.2, 112.1, 110.7, 105.4, 104.4, 103.4, 72.0, 71.5, 66.0, 65.7, 56.8, 56.2, 37.9, 22.3, 22.1, 20.8, 16.8 
Method B:
To a RBF containing 14 (100 mg, 0.13 mmol, 1.0 eq.) and 1,4-cyclohexadiene (0.3 mL, 3.2 mmol, 25 eq.) in MeOH (5 mL) and EtOAc (0.5 mL) was added 20% Pd(OH)2 on carbon (Pearlman's catalyst) (88 mg). After flushing with N2, the mixture was heated to 60 °C over 6 h. After this time K2CO3 (1.0 g) was added before cooling to rt and mixture was filtered over a 5 cm pad of diatomaceous earth, eluting with DCM (50 mL) into an RBF. The filtrate was directly dry-loaded onto SiO2 and purified by flash column chromatography (SiO2, 80:20) to give the title compound 5 (54 mg, 89%) as an off-white solid. IR νmax (thin film): 3469, 3375, 2978, 2950, 2349, 2154, 1695 (C=O), 1666, 1619, 1594, 1499, 1438, 1420, 1365, 1336, 1317, 1297, 1235, 1190, 1144, 1100, 1031, 1009, 991, 964, 924, 855cm 6, 151.3, 149.4, 148.7, 147.4, 146.8, 138.6, 132.4, 124.3, 123.5, 118.5, 112.3, 110.7, 109.8, 109.3, 105.4, 104.8, 103.8, 91.4, 77.5, 77.2, 76.8, 71.7, 71.5, 56.7, 56.3, 27.1, 22.1, 22.0 
4-Bromo-1-isopropoxy-2-methoxybenzene (4)
To a suspension of KOtBu (898 mg, 8.0 mmol, 4.0 eq.) in PhMe (2 mL) was added 2-propanol (690 μL, 9.0 mmol, 4.5 eq.) in anhydrous DMPU (2 mL) before the mixture was heated at 80 °C for 30 mins. After this time, 5-bromo-2-fluoroanisole 15 (410 mg, 2.0 mmol, 1.0 eq.) in anhydrous DMPU (1 mL) was added (syringe washed with further 0.2 mL DMPU), before a reflux condenser was immediately attached and the solution was stirred at 80 °C for a further 3 h. After this time, the mixture was cooled to rt before brine (20 mL) and n-pentane (20 mL) were sequentially added. After vigorous shaking of the biphasic mixture in a separating funnel, the organic layer was separated and filtered through a 5 cm plug of SiO2 and washed with n-pentane (20 mL). The solvent was evaporated to give the title compound 4
(401 mg, 82%) as colorless oil. IR νmax (thin film): 2975, 2933, 2830, 1585, 1493, 1464, 1444, 1397, 1383, 1372, 1322, 1290, 1248, 1221, 1178, 1133, 1107, 1028, 951, 868, 835, 813 1509, 1486, 1465, 1431, 1418, 1385, 1334, 1266, 1223, 1179, 1162, 1137, 1110, 1038, 1018, 945, 857 6, 151.4, 150.2, 148.5, 147.9, 147.2, 146.6, 146.5, 134.4, 129.4, 128.8, 124.7, 123.9, 123.2, 119.0, 116.9, 115.0, 112.3, 111.0, 110.4, 110.0, 107.8, 105.7, 105.5, 103.4, 71.8, 71.5, 71.2, 56.2, 55.5, 55.2, 21 .821.9 ( 1H, s), 9.84 (1H, s), 9.34 (1H, s), 8.99 (1H, d, J = 7.4 Hz), 7.20 (1H, d, J = 7.4 Hz) 4, 148.7, 148.5, 148.4, 147.9, 146.9, 146.4, 144.6, 134.1, 129.0, 125.5, 124.7, 123.9, 122.1, 117.6, 116.5, 115.1, 112.4, 111.6, 110.9, 108.4, 106.4, 105.8, 105.4, 103.8, 56.0, 55. Spectroscopic data are consistent with those previously reported. 5
2-(4-Isopropoxyphenyl)acetonitrile (22)
2-Bromopropane (14 mL, 0.15 mol, 1.5 eq.) was added to a mixture of 4-hydroxyphenylacetonitrile (13.3 g, 0.1 mol, 1.0 eq.) and K2CO3 (28 g, 0.2 mol, 2.0 eq.) in DMSO (50 mL). The reaction mixture was stirred at 60 °C for 21 h and then left to cool to rt. Water (100 mL) was added and the aqueous layer extracted with DCM (4 × 80 mL). The combined organic extracts were washed with brine, dried with Na2SO4, filtered and concentrated in vacuo to give the title compound 22 (17 g, >99%) as pale-yellow needles. m.p. 26-28 C (n-pentane/Et2O); IR νmax 3042, 2976 and 2906, 2248, 1611, 1581, 1508, 1469, 1452, 1416, 1380, 1373, 1352, 1333, 1304, 1286, 1246, 1205, 1180, 1137, 1117, 1103, 1013, 953, 925, 902, 863, 832, 806 
2-Bromo-2-(4-isopropoxyphenyl)acetonitrile (20)
To a two-neck RBF was added dibenzoyl peroxide (97 mg, 0.04 mmol, 4 mol%), 2-(4-isopropoxyphenyl)acetonitrile 22 (1.75 g, 10 mmol, 1.0 eq.) and NBS (2.67 g, 15 mmol, 1.5 eq.). Diethyl carbonate (which had been degassed by freeze-pump-thaw cycles) (50 mL) was added under argon before heating to 100 °C, over 24 h. The reaction mixture was left to cool to rt and concentrated in vacuo. The residue was triturated with pentane/Et2O, filtered and washed with Et2O. The filtrate was concentrated in vacuo and flash column chromatography (SiO2; n-pentane/acetone, 96:4) gave the title compound 20
(1.53 g, 60%) as orange oil. IR νmax 2978 and 2935, 2247, 1606, 1582, 1509, 1466, 1454, 1428, 3070, 3038, 2977, 2929, 2887, 2236, 1751, 1610, 1581, 1508, 1469, 1399, 1384, 1372, 1350, 1301, 1243, 1178, 1119, 1106, 1083, 1065, 103, 1003, 954, 879, 858, 843 194.4, 158.0, 157.7, 130.2, 129.6, 125.8, 125.4, 119.7, 116.1, 115.9, 103.6, 72.9, 69.9, 69.8, 56.0, 40.6 , 30.8, 22.07, 22.06, 22.0, 14 
Methyl 5-bromo-3,4-bis(4-isopropoxyphenyl)-1H-pyrrole-2-carboxylate (24)
A solution of 18 (143.9 mg, 0.3 mmol) in DCM/Et2O (1:1, 2 mL) was added dropwise to a solution of 33% HBr in AcOH (920 μL) at 0 °C and the mixture left stirring at this temperature for 30 min. After this time, the mixture left to warm to rt. After 3 h the reaction mixture was poured onto crushed ice and adjusted to ca. pH 7-8 (as judged by pH indicator paper) by slow addition of K2CO3. The solution was then extracted with DCM (4 × 50 mL), and the combined organic extracts dried with Na2SO4, filtered and concentrated in vacuo. The remaining residue was dissolved in MeOH (9 mL) and K2CO3 (82.9 mg, 0.6 mmol, 2 eq.) was added. The mixture heated at 65 °C for 4 h. Then the mixture left to cool to rt, dry loaded onto SiO2 and purified by flash column chromatography (SiO2; n-pentane/ Et2O, 80:20) 
